Advertisement

With Important Trial Results Due in June, Is This Drugmaker a Good Buy Now?

With Important Trial Results Due in June, Is This Drugmaker a Good Buy Now?

The company faced challenges last year in expanding the label of its only drug. Will 2021 bring different results?